Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Accounts Payables (2020 - 2024)

Historic Accounts Payables for Molecular Partners Ag (MOLN) over the last 6 years, with Q3 2025 value amounting to $2653.9.

  • Molecular Partners Ag's Accounts Payables fell 347.05% to $2653.9 in Q3 2025 from the same period last year, while for Sep 2025 it was $2653.9, marking a year-over-year decrease of 347.05%. This contributed to the annual value of $2113.1 for FY2024, which is 9985.89% down from last year.
  • As of Q3 2025, Molecular Partners Ag's Accounts Payables stood at $2653.9, which was down 347.05% from $2380.8 recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Accounts Payables ranged from a high of $8.0 million in Q4 2021 and a low of $2122.1 during Q4 2024
  • Over the past 5 years, Molecular Partners Ag's median Accounts Payables value was $3607.8 (recorded in 2024), while the average stood at $1.5 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first surged by 2436.67% in 2021, then plummeted by 9992.47% in 2025.
  • Quarter analysis of 5 years shows Molecular Partners Ag's Accounts Payables stood at $8.0 million in 2021, then crashed by 72.24% to $2.2 million in 2022, then tumbled by 32.7% to $1.5 million in 2023, then tumbled by 99.86% to $2122.1 in 2024, then grew by 25.06% to $2653.9 in 2025.
  • Its Accounts Payables stands at $2653.9 for Q3 2025, versus $2380.8 for Q2 2025 and $2665.0 for Q1 2025.